BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 25066726)

  • 1. Patterns of DNA damage response in intracranial germ cell tumors versus glioblastomas reflect cell of origin rather than brain environment: implications for the anti-tumor barrier concept and treatment.
    Bartkova J; Hoei-Hansen CE; Krizova K; Hamerlik P; Skakkebæk NE; Rajpert-De Meyts E; Bartek J
    Mol Oncol; 2014 Dec; 8(8):1667-78. PubMed ID: 25066726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rotavirus activates a noncanonical ATM-Chk2 branch of DNA damage response during infection to positively regulate viroplasm dynamics.
    Sarkar R; Patra U; Lo M; Mukherjee A; Biswas A; Chawla-Sarkar M
    Cell Microbiol; 2020 Mar; 22(3):e13149. PubMed ID: 31845505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA damage response in human testes and testicular germ cell tumours: biology and implications for therapy.
    Bartkova J; Rajpert-De Meyts E; Skakkebaek NE; Lukas J; Bartek J
    Int J Androl; 2007 Aug; 30(4):282-91; discussion 291. PubMed ID: 17573848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential DNA Damage Response of Peripheral Blood Lymphocyte Populations.
    Felgentreff K; Schuetz C; Baumann U; Klemann C; Viemann D; Ursu S; Jacobsen EM; Debatin KM; Schulz A; Hoenig M; Schwarz K
    Front Immunol; 2021; 12():739675. PubMed ID: 34594342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Replication stress and oxidative damage contribute to aberrant constitutive activation of DNA damage signalling in human gliomas.
    Bartkova J; Hamerlik P; Stockhausen MT; Ehrmann J; Hlobilkova A; Laursen H; Kalita O; Kolar Z; Poulsen HS; Broholm H; Lukas J; Bartek J
    Oncogene; 2010 Sep; 29(36):5095-102. PubMed ID: 20581868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initiation of the ATM-Chk2 DNA damage response through the base excision repair pathway.
    Chou WC; Hu LY; Hsiung CN; Shen CY
    Carcinogenesis; 2015 Aug; 36(8):832-40. PubMed ID: 26025911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA damage response mediators MDC1 and 53BP1: constitutive activation and aberrant loss in breast and lung cancer, but not in testicular germ cell tumours.
    Bartkova J; Horejsí Z; Sehested M; Nesland JM; Rajpert-De Meyts E; Skakkebaek NE; Stucki M; Jackson S; Lukas J; Bartek J
    Oncogene; 2007 Nov; 26(53):7414-22. PubMed ID: 17546051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of DNA damage response signaling biomarkers using automated, quantitative image analysis.
    Nikolaishvilli-Feinberg N; Cohen SM; Midkiff B; Zhou Y; Olorvida M; Ibrahim JG; Omolo B; Shields JM; Thomas NE; Groben PA; Kaufmann WK; Miller CR
    J Histochem Cytochem; 2014 Mar; 62(3):185-96. PubMed ID: 24309508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Replication stress, DNA damage signalling, and cytomegalovirus infection in human medulloblastomas.
    Bartek J; Fornara O; Merchut-Maya JM; Maya-Mendoza A; Rahbar A; Stragliotto G; Broholm H; Svensson M; Sehested A; Söderberg Naucler C; Bartek J; Bartkova J
    Mol Oncol; 2017 Aug; 11(8):945-964. PubMed ID: 28383788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of ATR selectively sensitizes ATM-deficient human mammary epithelial cells to ionizing radiation and DNA-damaging agents.
    Cui Y; Palii SS; Innes CL; Paules RS
    Cell Cycle; 2014; 13(22):3541-50. PubMed ID: 25483091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic implications of the DNA damage response pathway in glioblastoma.
    Seol HJ; Yoo HY; Jin J; Joo KM; Kong DS; Yoon SJ; Yang H; Kang W; Lim DH; Park K; Kim JH; Lee JI; Nam DH
    Oncol Rep; 2011 Aug; 26(2):423-30. PubMed ID: 21617879
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA damage response in renal ischemia-reperfusion and ATP-depletion injury of renal tubular cells.
    Ma Z; Wei Q; Dong G; Huo Y; Dong Z
    Biochim Biophys Acta; 2014 Jul; 1842(7):1088-96. PubMed ID: 24726884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Checkpoint kinase 2 (Chk2) supports sensitivity to platinum-based treatment in high grade serous ovarian cancer.
    Alkema NG; Tomar T; van der Zee AG; Everts M; Meersma GJ; Hollema H; de Jong S; van Vugt MA; Wisman GB
    Gynecol Oncol; 2014 Jun; 133(3):591-8. PubMed ID: 24657486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA damage response as an anti-cancer barrier: damage threshold and the concept of 'conditional haploinsufficiency'.
    Bartek J; Lukas J; Bartkova J
    Cell Cycle; 2007 Oct; 6(19):2344-7. PubMed ID: 17700066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Critical role of CCDC6 in the neoplastic growth of testicular germ cell tumors.
    Staibano S; Ilardi G; Leone V; Luise C; Merolla F; Esposito F; Morra F; Siano M; Franco R; Fusco A; Chieffi P; Celetti A
    BMC Cancer; 2013 Sep; 13():433. PubMed ID: 24059746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogen-induced B-cell proliferation activates Chk2-dependent G1/S cell cycle arrest.
    Nikitin PA; Price AM; McFadden K; Yan CM; Luftig MA
    PLoS One; 2014; 9(1):e87299. PubMed ID: 24498068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage signalling guards against activated oncogenes and tumour progression.
    Bartek J; Bartkova J; Lukas J
    Oncogene; 2007 Dec; 26(56):7773-9. PubMed ID: 18066090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining the ATM-mediated barrier to tumorigenesis in somatic mammary cells following ErbB2 activation.
    Reddy JP; Peddibhotla S; Bu W; Zhao J; Haricharan S; Du YC; Podsypanina K; Rosen JM; Donehower LA; Li Y
    Proc Natl Acad Sci U S A; 2010 Feb; 107(8):3728-33. PubMed ID: 20133707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas.
    Squatrito M; Brennan CW; Helmy K; Huse JT; Petrini JH; Holland EC
    Cancer Cell; 2010 Dec; 18(6):619-29. PubMed ID: 21156285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA damage response-related proteins in gastric cancer: ATM, Chk2 and p53 expression and their prognostic value.
    Lee HE; Han N; Kim MA; Lee HS; Yang HK; Lee BL; Kim WH
    Pathobiology; 2014; 81(1):25-35. PubMed ID: 23969480
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.